Contribution: Industrial Research Assistance Program – Contributions to Firms
Serenity Bioworks Inc.
$90,000.00
Development of immunomodulatory biotherapeutics for the treatment of lupus nephritis
FY 2021-22 · 2021-05-02
Summary
Serenity Bioworks is conducting drug-development studies to gain a better understanding of the interaction and effectiveness of its lead biotherapeutic in combination with the standard of care drugs in an autoimmune disease, lupus nephritis.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Kitchener|Kitchener, Ontario, Canada
Recipient Type
For-profit organization
Business Number
718540891
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
As published
Agreement End Date
2022-03-31
Agreement Number
976913
Agreement Start Date
2021-05-02
Agreement Title
Development of immunomodulatory biotherapeutics for the treatment of lupus nephritis
Agreement Title (French)
Développement de produits biothérapeutiques immunomodulateurs pour le traitement du lupus néphrétique
Agreement Type
Contribution
Agreement Value
$90,000.00
Amendment Number
0
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Serenity Bioworks is conducting drug-development studies to gain a better understanding of the interaction and effectiveness of its lead biotherapeutic in combination with the standard of care drugs in an autoimmune disease, lupus nephritis.
Description (French)
Serenity Bioworks mène des études de développement de médicaments pour mieux comprendre l'interaction et l'efficacité de son principal produit biothérapeutique en combinaison avec les médicaments de référence dans une maladie auto-immune, le lupus néphrétique.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Kitchener Centre
Federal Riding (French)
Kitchener-Centre
Federal Riding Number
35045
NAICS Code
3254
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
718540891
Recipient City
Kitchener|Kitchener
Recipient Country
CA
Recipient Legal Name
Serenity Bioworks Inc.
Recipient Postal Code
N2G 1H6
Recipient Province or Territory
ON
Recipient Type
F
Reference Number
172-2021-2022-Q2-976913
